Risk assessment of short-term intake of pyrrolizidine alkaloids in food: derivation of an acute reference dose

References

• Allemang A, Mahony C, Lester C, Pfuhler S. 2018. Relative potency of fifteen pyrrolizidine alkaloids to induce DNA damage as measured by micronucleus induction in HepaRG human liver cells. Food Chem Toxicol. 121:72–81. doi:10.1016/j.fct.2018.08.003
   PubMed Web of Science ®Google Scholar
• ANZFA (Australia New Zealand Food Authority). 2001. Pyrrolizidine alkaloids in food: a toxicological review and risk assessment. Technical Report Series No.2. ISBN 0 642 34501 5. https://www.foodstandards.gov.au/publications/documents/TR2.pdf. [accessed 2021 Jan 27].
   Google Scholar
• BfR (Bundesinstitut für Riskiobewertung). 2020. Aktualisierte Risikobewertung zu Gehalten an 1,2-ungesättigten Pyrrolizidinalkaloiden (PA) in Lebensmitteln: stellungnahme Nr. 026/2020 des BfR vom 17. Juni 2020. doi:10.17590/20200617-130910
   Google Scholar
• Buchmueller J, Enge A-M, Peters A, Ebmeyer J, Küpper J-H, Schäfer B, Braeuning A, Hessel-Pras S. 2022. The chemical structure impairs the intensity of genotoxic effects promoted by 1,2-unsaturated pyrrolizidine alkaloids in vitro. Food Chem Toxicol. 164:113049. doi:10.1016/j.fct.2022.113049
   PubMed Web of Science ®Google Scholar
• Casado N, Morante-Zarcero S, Sierra I. 2022. The concerning food safety issue of pyrrolizidine alkaloids: an overview. Trends Food Sci Technol. 120:123–139. doi:10.1016/j.tifs.2022.01.007
   Web of Science ®Google Scholar
• Chen Z, Huo J-R. 2010. Hepatic veno-occlusive disease associated with toxicity of pyrrolizidine alkaloids in herbal preparations. Neth J Med. 68(6):252–260.
   PubMed Web of Science ®Google Scholar
• Chen L, Mulder PPJ, Louisse J, Peijnenburg A, Wesseling S, Rietjens IMCM. 2017. Risk assessment for pyrrolizidine alkaloids detected in (herbal) teas and plant food supplements. Regul Toxicol Pharmacol. 86:292–302. doi:10.1016/j.yrtph.2017.03.019
   PubMed Web of Science ®Google Scholar
• Chen T, Mei N, Fu PP. 2010. Genotoxicity of pyrrolizidine alkaloids. J Appl Toxicol. 30(3):183–196. doi:10.1002/jat.1504
   PubMed Web of Science ®Google Scholar
• Chen Y, Mulder PPJ, Schaap O, Memelink J, Klinkhamer PGL, Vrieling K. 2022. The evolution of pyrrolizidine alkaloid diversity among and within Jacobaea species. J Syt Evol. 60(2):361–376. doi:10.1111/jse.12671
   Web of Science ®Google Scholar
• Chojkier M. 2003. Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids. J Hepatol. 39(3):437–446. doi:10.1016/S0168-8278(03)00231-9
   PubMed Web of Science ®Google Scholar
• Dusemund B, Nowak N, Sommerfeld C, Lindtner O, Schäfer B, Lampen A. 2018. Risk assessment of pyrrolizidine alkaloids in food of plant and animal origin. Food Chem Toxicol. 115:63–72. doi:10.1016/j.fct.2018.03.005
   PubMed Web of Science ®Google Scholar
• EFSA (European Food Safety Authority). 2017. Risks for human health related to the presence of pyrrolizidine alkaloids in honey, tea, herbal infusions and food supplements. Efsa J. 15:e04908. doi:10.2903/j.efsa.2017.4908
   PubMed Web of Science ®Google Scholar
• EMA (European Medicines Agency). 2021. Public statement on the use of herbal medicinal products containing toxic, unsaturated pyrrolizidine alkaloids (PAs) including recommendations regarding contamination of herbal medicinal products with PAs. Committee on Herbal Medicinal Products (HMPC). https://www.ema.europa.eu/en/documents/public-statement/draft-public-statement-use-herbal-medicinal-products-containing-toxic-unsaturated-pyrrolizidine_en-0.pdf.
   Google Scholar
• Fox DW, Hart MC, Bergeson PS, Jarrett PB, Stillman AE, Huxtable RJ. 1978. Pyrrolizidine (Senecio) intoxication mimicking Reye syndrome. J Pediatr. 93(6):980–982. doi:10.1016/S0022-3476(78)81227-X
   PubMed Web of Science ®Google Scholar
• Fu PP. 2017. Pyrrolizidine alkaloids: metabolic activation pathways leading to liver tumor initiation. Chem Res Toxicol. 30(1):81–93. doi:10.1021/acs.chemrestox.6b00297
   PubMed Web of Science ®Google Scholar
• Fu PP, Xia Q, Lin G, Chou MW. 2004. Pyrrolizidine alkaloids – genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev. 36(1):1–55. doi:10.1081/DMR-120028426
   PubMed Web of Science ®Google Scholar
• Gottschalk C, Kaltner F, Zimmermann M, Korten R, Morris O, Schwaiger K, Gareis M. 2020. Spread of jacobaea vulgaris and occurrence of pyrrolizidine alkaloids in regionally produced honeys from northern Germany: inter- and intra-site variations and risk assessment for special consumer groups. Toxins. 12(7):441. doi:10.3390/toxins12070441
   PubMed Web of Science ®Google Scholar
• Hessel S, Gottschalk C, Schumann D, These A, Preiss-Weigert A, Lampen A. 2014. Structure-activity relationship in the passage of different pyrrolizidine alkaloids through the gastrointestinal barrier: ABCB1 excretes heliotrine and echimidine. Mol Nutr Food Res. 58(5):995–1004. doi:10.1002/mnfr.201300707
   PubMed Web of Science ®Google Scholar
• Hessel-Pras S, Braeuning A, Guenther G, Adawy A, Enge A-M, Ebmeyer J, Henderson CJ, Hengstler JG, Lampen A, Reif R. 2020. The pyrrolizidine alkaloid senecionine induces CYP-dependent destruction of sinusoidal endothelial cells and cholestasis in mice. Arch Toxicol. 94(1):219–229. doi:10.1007/s00204-019-02582-8
   PubMed Web of Science ®Google Scholar
• Hoogenboom LAP, Mulder PPJ, Zeilmaker MJ, van den Top HJ, Remmelink GJ, Brandon EFA, Klijnstra M, Meijer GAL, Schothorst R, Van Egmond HP. 2011. Carry-over of pyrrolizidine alkaloids from feed to milk in dairy cows. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 28(3):359–372. doi:10.1080/19440049.2010.547521
   PubMed Web of Science ®Google Scholar
• IARC (International Agency for Research on Cancer). 2002. Senecio species and riddelliine. In: Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 82. https://publications.iarc.fr/_publications/media/download/2630/8c01b73169a9774f560bf7721bdf5da9171da880.pdf. [accessed 2021 Jan 27].
   Google Scholar
• JECFA (Joint FAO/WHO Expert Committee on Food Additives). 2020. Supplement 2: pyrrolizidine alkaloids. In: Safety Evaluation of Certain Food Additives and Contaminants. WHO Food Additives Series 71-S2. https://apps.who.int/iris/rest/bitstreams/1318952/retrieve.
   Google Scholar
• Kakar F, Akbarian Z, Leslie T, Mustafa ML, Watson J, van Egmond HP, Omar MF, Mofleh J. 2010. An outbreak of hepatic veno-occlusive disease in Western afghanistan associated with exposure to wheat flour contaminated with pyrrolizidine alkaloids. J Toxicol. 2010:313280. doi:10.1155/2010/313280
   PubMedGoogle Scholar
• Kaltner F, Kukula V, Gottschalk C. 2020. Screening of food supplements for toxic pyrrolizidine alkaloids. J Consum Prot Food Saf. 15(3):237–243. doi:10.1007/s00003-020-01296-9
   Web of Science ®Google Scholar
• Keuth O, Humpf HU, Fürst P. 2022. Determination of pyrrolizidine alkaloids in tea and honey with automated SPE clean-up and ultra-performance liquid chromatography/tandem mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 39(1):149–157. doi:10.1080/19440049.2021.1982149
   PubMed Web of Science ®Google Scholar
• Koleva II, Beek TA, van Soffers AEMF, Dusemund B, Rietjens IMCM. 2012. Alkaloids in the human food chain – Natural occurrence and possible adverse effects. Mol Nutr Food Res. 56(1):30–52. doi:10.1002/mnfr.201100165
   PubMed Web of Science ®Google Scholar
• Lester C, Troutman J, Obringer C, Wehmeyer K, Stoffolano P, Karb M, Xu Y, Roe A, Carr G, Blackburn K, et al. 2019. Intrinsic relative potency of a series of pyrrolizidine alkaloids characterized by rate and extent of metabolism. Food Chem Toxicol. 131:110523. doi:10.1016/j.fct.2019.05.031
   PubMed Web of Science ®Google Scholar
• Louisse J, Rijkers D, Stoopen G, Holleboom WJ, Delagrange M, Molthof E, Mulder PPJ, Hoogenboom RLAP, Audebert M, Peijnenburg AACM. 2019. Determination of genotoxic potencies of pyrrolizidine alkaloids in HepaRG cells using the γH2AX assay. Food Chem Toxicol. 131:110532. doi:10.1016/j.fct.2019.05.040
   PubMed Web of Science ®Google Scholar
• Ma J, Xia Q, Fu PP, Lin G. 2018. Pyrrole-protein adducts – a biomarker of pyrrolizidine alkaloid-induced hepatotoxicity. J Food Drug Anal. 26(3):965–972. doi:10.1016/j.jfda.2018.05.005
   PubMed Web of Science ®Google Scholar
• Mädge I, Gehling M, Schöne C, Winterhalter P, These A. 2020. Pyrrolizidine alkaloid profiling of four Boraginaceae species from Northern Germany and implications for the analytical scope proposed for monitoring of maximum levels. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 37(8):1339–1358. doi:10.1080/19440049.2020.1757166
   PubMed Web of Science ®Google Scholar
• Merz K-H, Schrenk D. 2016. Interim relative potency factors for the toxicological risk assessment of pyrrolizidine alkaloids in food and herbal medicines. Toxicol Lett. 263:44–57. doi:10.1016/j.toxlet.2016.05.002
   PubMed Web of Science ®Google Scholar
• Mohabbat O, Younos MS, Merzad AA, Srivastava RN, Sediq GG, Aram GN. 1976. An outbreak of hepatic veno-occlusive disease in north-western Afghanistan. Lancet. 2(7980):269–271. doi:10.1016/S0140-6736(76)90726-1
   PubMed Web of Science ®Google Scholar
• Mol HGJ, van Dam RCJ, Zomer P, Mulder PPJ. 2011. Screening of plant toxins in food, feed and botanicals using full-scan high-resolution (Orbitrap) mass spectrometry. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 28(10):1405–1423. doi:10.1080/19440049.2011.603704
   PubMed Web of Science ®Google Scholar
• Moreira R, Pereira DM, Valentão P, Andrade PB. 2018. Pyrrolizidine alkaloids: chemistry, pharmacology, toxicology and food safety. IJMS. 19(6):1668. doi:10.3390/ijms19061668
   Google Scholar
• Mulder PPJ, Klijnstra MD, Goselink RMA, Vuuren AM, van Cone JW, Stoopen G, Hoogenboom RLAP. 2020. Transfer of pyrrolizidine alkaloids from ragwort, common groundsel and viper’s bugloss to milk from dairy cows. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 37(11):1906–1921. doi:10.1080/19440049.2020.1798028
   PubMed Web of Science ®Google Scholar
• Mulder PPJ, Sánchez PL, These A, Preiss‐Weigert A, Castellari M. 2015. Occurrence of pyrrolizidine alkaloids in food. EFS3. 12(8):859E. doi:10.2903/sp.efsa.2015.EN-859
   Google Scholar
• NTP (National Toxicology Program). 1993. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice. Toxicity Report Series 27, 1-D9. https://ntp.niehs.nih.gov/ntp/htdocs/st_rpts/tox027.pdf. [accessed 2021 Jan 27].
   Google Scholar
• NTP (National Toxicology Program). 2003. NTP Technical report on the toxicology and carcinogenesis studies of riddelliine (CAS No. 23246-96-0) in F344/N rats and B6C3F1 mice (gavage studies). https://ntp.niehs.nih.gov/ntp/htdocs/lt_rpts/tr508.pdf?utm_source=direct&utm_medium=prod&utm_campaign=ntpgolinks&utm_term=tr508. [accessed 2021 Jan 27].
   Google Scholar
• Prakash AS, Pereira TN, Reilly PEB, Seawright AA. 1999. Pyrrolizidine alkaloids in human diet. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 443(1–2):53–67. doi:10.1016/S1383-5742(99)00010-1
   PubMed Web of Science ®Google Scholar
• Ridker PM, Ohkuma S, McDermott WV, Trey C, Huxtable RJ. 1985. Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology. 88(4):1050–1054. doi:10.1016/S0016-5085(85)80027-5
   PubMed Web of Science ®Google Scholar
• RIVM (Dutch National Institute for Public Health and the Environment). 2014. Pyrrolizidine alkaloids in herbal preparations. RIVM Briefrapport 090437001/2014. https://www.rivm.nl/bibliotheek/rapporten/090437001.pdf.
   Google Scholar
• Rutz L, Gao L, Küpper JH, Schrenk D. 2020. Structure-dependent genotoxic potencies of selected pyrrolizidine alkaloids in metabolically competent HepG2 cells. Arch Toxicol. 94(12):4159–4172. doi:10.1007/s00204-020-02895-z
   PubMed Web of Science ®Google Scholar
• Schramm S, Köhler N, Rozhon W. 2019. Pyrrolizidine alkaloids: biosynthesis, biological activities and occurrence in crop plants. Molecules. 24(3):498. doi:10.3390/molecules24030498
   PubMed Web of Science ®Google Scholar
• Schrenk D, Fahrer J, Allemang A, Fu P, Lin G, Mahony C, Mulder PPJ, Peijnenburg A, Pfuhler S, Rietjens  , et al. 2022. Novel insights into pyrrolizidine alkaloid toxicity and implications for risk assessment: occurrence, genotoxicity, toxicokinetics, risk assessment-a workshop report. Planta Med. 88(2):98–117. doi:10.1055/a-1646-3618
   PubMedGoogle Scholar
• Schrenk D, Gao L, Lin G, Mahony C, Mulder PPJ, Peijnenburg A, Pfuhler S, Rietjens IMCM, Rutz L, Steinhoff B, et al. 2020. Pyrrolizidine alkaloids in food and phytomedicine: occurrence, exposure, toxicity, mechanisms, and risk assessment – a review. Food Chem Toxicol. 136:111107. doi:10.1016/j.fct.2019.111107
   PubMed Web of Science ®Google Scholar
• Sperl W, Stuppner H, Gassner I, Judmaier W, Dietze O, Vogel W. 1995. Reversible hepatic veno-occlusive disease in an infant after consumption of pyrrolizidine-containing herbal tea. Eur J Pediatr. 154(2):112–116. doi:10.1007/BF01991912
   PubMed Web of Science ®Google Scholar
• Stedman C. 2002. Herbal hepatotoxicity. Semin Liver Dis. 22(2):195–206. doi:10.1055/s-2002-30104
   PubMed Web of Science ®Google Scholar
• Steinhoff B. 2019. Pyrrolizidine alkaloid contamination in herbal medicinal products: limits and occurrence. Food Chem Toxicol. 130:262–266. doi:10.1016/j.fct.2019.05.026
   PubMed Web of Science ®Google Scholar
• Steinhoff B. 2022. Pyrrolizidine alkaloid contamination in medicinal plants: regulatory requirements and their impact on production and quality control of herbal medicinal products. Planta Med. 88(2):125–129. doi:10.1055/a-1494-3623
   PubMedGoogle Scholar
• Stewart MJ, Steenkamp V. 2001. Pyrrolizidine poisoning: a neglected area in human toxicology. Ther Drug Monit. 23(6):698–708. doi:10.1097/00007691-200112000-00018
   PubMed Web of Science ®Google Scholar
• Stillman AS, Huxtable R, Consroe P, Kohnen P, Smith S. 1977. Hepatic veno-occlusive disease due to pyrrolizidine (Senecio) poisoning in Arizona. Gastroenterology. 73(2):349–352. doi:10.1016/S0016-5085(19)32224-3
   PubMed Web of Science ®Google Scholar
• These A, Bodi D, Ronczka S, Lahrssen-Wiederholt M, Preiss-Weigert A. 2013. Structural screening by multiple reaction monitoring as a new approach for tandem mass spectrometry: presented for the determination of pyrrolizidine alkaloids in plants. Anal Bioanal Chem. 405(29):9375–9383. doi:10.1007/s00216-013-7365-4
   PubMed Web of Science ®Google Scholar
• Yang M, Ma J, Ruan J, Ye Y, Fu PP, Lin G. 2019. Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids. Arch Toxicol. 93(8):2197–2209. doi:10.1007/s00204-019-02499-2
   PubMed Web of Science ®Google Scholar
• Yang M, Ma J, Ruan J, Zhang C, Ye Y, Pi-Cheng Fu P, Lin G. 2020. Absorption difference between hepatotoxic pyrrolizidine alkaloids and their N-oxides – mechanism and its potential toxic impact. J Ethnopharmacol. 249:112421. doi:10.1016/j.jep.2019.112421
   PubMed Web of Science ®Google Scholar
• Zhuge YZ, Wang Y, Zhang F, Zhu CK, Zhang W, Zhang M, He Q, Yang J, He J, Chen J, et al. 2018. Clinical characteristics and treatment of pyrrolizidine alkaloid-related hepatic vein occlusive disease. Liver Int. 38(10):1867–1874. doi:10.1111/liv.13684
   PubMed Web of Science ®Google Scholar